ChemBK
Home
Product Category
Suppliers
Search
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-, (2E)-
Request for Quotation
4-Hydroxy 4-Dedimethylamino Afatinib
CAS: 2121530-37-6
Molecular Formula: C22H20ClFN4O4
Home
Product Category
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-, (2E)-
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-, (2E)- -
Names and Identifiers
Name
4-Hydroxy 4-Dedimethylamino Afatinib
Synonyms
Afatinib 4-Hydroxy Analog
Afatinib Maleate Acid Impurity 3
4-Hydroxy 4-Dedimethylamino Afatinib
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-, (2E)-
(2E)?-N-?[4-?[(3-?chloro-?4-?fluorophenyl)?amino]?-?7-?[[(3S)?-?tetrahydro-?3-?furanyl]?oxy]?-?6-?quinazolinyl]?-?4-?hydroxy-2-?butenamide
CAS
2121530-37-6
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-, (2E)- -
Physico-chemical Properties
Molecular Formula
C22H20ClFN4O4
Molar Mass
458.87
View 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-, (2E)- structural formula
Supplier List
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Afatinib Impurity 23
Visit Supplier Webpage
Request for quotation
CAS: 2121530-37-6
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Spot supply
Product Name:
Afatinib Impurity 23
Visit Supplier Webpage
Request for quotation
CAS: 2121530-37-6
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
View History
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-hydroxy-, (2E)-
Home
Product Category
© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001